The International Association for the Study of Lung Cancer Thymic Tumors Staging Project: The Impact of the Eighth Edition of the Union for International Cancer Control and American Joint Committee on Cancer TNM Stage Classification of Thymic Tumors.


Journal

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
ISSN: 1556-1380
Titre abrégé: J Thorac Oncol
Pays: United States
ID NLM: 101274235

Informations de publication

Date de publication:
03 2020
Historique:
received: 18 08 2019
revised: 27 10 2019
accepted: 17 11 2019
pubmed: 30 11 2019
medline: 7 1 2021
entrez: 30 11 2019
Statut: ppublish

Résumé

The International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee-Thymic Domain conducted a web-based cross-sectional survey to assess the acceptance of the TNM thymic staging system in the thoracic community. A 50-item, web-based questionnaire was circulated among the members of the major thymic organizations worldwide from September to December 2018. The survey consisted of six sections (general information; overall perception of the TNM system; pretreatment staging; T category; N category; and perioperative treatments). In total, 217 responses were collected from 37 countries in four continents. The TNM classification was considered useful by 78% of the responders (N = 169); the Masaoka-Koga staging system was being used by 87% of the responders (N = 189). With regard to the T category, most responders (mostly surgeons) felt that the capsular and mediastinal pleural involvements should be considered separate T categories. As for the N category, 48% of the responders (N = 105) used the International Thymic Malignancies Interest Group/International Association for the Study of Lung Cancer thymic nodal map, and lymph node dissection (N1/N2) was performed for 50%/21% thymomas and 66%/41% thymic carcinomas. While analyzing the results by the three continents (Europe, Asia, and Americas), responders in Asia were found to report the largest use of the TNM system, the greatest attention to the N category, and the best participation in international thymic databases. The survey indicates that the Union for International Cancer Control/American Joint Committee on Cancer TNM stage classification of thymic tumors is gaining acceptance among the scientific community. The present results will guide the work of the Staging and Prognostic Factors Committee-Thymic Domain for the revision of the ninth edition of the TNM stage classification of thymic tumors.

Identifiants

pubmed: 31783179
pii: S1556-0864(19)33667-6
doi: 10.1016/j.jtho.2019.11.013
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

436-447

Informations de copyright

Copyright © 2019 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

Auteurs

Enrico Ruffini (E)

University of Torino, Thoracic Surgery, Torino, Italy. Electronic address: enrico.ruffini@unito.it.

Wentao Fang (W)

Shanghai Chest Hospital, Jiaotong University Medical School, Thoracic Surgery, Shanghai, People's Republic of China.

Francesco Guerrera (F)

University of Torino, Thoracic Surgery, Torino, Italy.

James Huang (J)

Memorial Sloan Kettering Cancer Center, Thoracic Surgery, New York, New York.

Meinoshin Okumura (M)

Osaka Toneyama Medical Center, Thoracic Surgery, Osaka, Japan.

Dong Kwan Kim (DK)

Asan Medical Center, Thoracic Surgery, Seoul, Republic of South Korea; University of Ulsan College of Medicine, Thoracic Surgery, Seoul, Republic of South Korea.

Nicolas Girard (N)

Institut Curie, Medical Oncology, Paris, France.

Andrea Billè (A)

Guy's Hospital, Thoracic Surgery, London, United Kingdom.

Souheil Boubia (S)

CHU Ibn Rochd, Thoracic Surgery, Casablanca, Morocco.

Ayten Kayi Cangir (AK)

Ankara University Faculty of Medicine, Thoracic Surgery, Ankara, Turkey.

Frank Detterbeck (F)

Yale University School of Medicine, Thoracic Surgery, New Haven.

Conrad Falkson (C)

Queen's University in Kingston, Radiation Oncology, Ontario, Canada.

Pier Luigi Filosso (PL)

University of Torino, Thoracic Surgery, Torino, Italy.

Giuseppe Giaccone (G)

Weill Cornell Medicine, Medical Oncology, New York, New York.

Kazuya Kondo (K)

Tokushima University, Department Oncological Medical Services, Tokushima, Japan.

Maurizio Infante (M)

University and Hospital Trust, Thoracic Surgery, Verona, Italy.

Marco Lucchi (M)

Azienda Ospedaliero-Universitaria Pisana, Thoracic Surgery, Pisa, Italy.

Mirella Marino (M)

IRCCS Regina Elena National Cancer Institute, Pathology, Rome, Italy.

Edith M Marom (EM)

University of Texas MD Anderson Cancer Center, Houston, Texas; University of Tel Aviv, the Chaim Sheba Medical Center, Radiology, Tel Aviv, Israel.

Andrew G Nicholson (AG)

Royal Brompton and Harefield NHS Foundation Trust and National Heart and Lung Institute, Imperial College, Pathology, London, United Kingdom.

Andreas Rimner (A)

Memorial Sloan Kettering Cancer Center, Thoracic Surgery, New York, New York.

Ramon Rami-Porta (R)

Hospital Universitari Mutua Terrassa, Terrassa, Spain, and Network of Centers for Biomedical Research in Respiratory Diseases Lung Cancer Group, Thoracic Surgery, Terrassa, Spain.

Hisao Asamura (H)

Keio University, Thoracic Surgery, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH